LAVAL, Quebec, March 31, 2011 (GLOBE NEWSWIRE) -- Acasti Pharma (“Acasti”) (TSX-V:APO), a Neptune Technologies & Bioressources Inc. (“Neptune”) subsidiary, announces that its shares will start trading today under APO ticker on the TSX-Venture Exchange (the “TSX-V” or “Exchange”).
